Empowering Medication Safety Through AI-Enhanced Drug Safety Intelligence
RxReport.ai is a next-generation platform designed to advance real-time drug safety intelligence, support pharmacovigilance, and amplify trust in medication data — powered by AI and built to serve pharmacists, providers, and public health leaders.
Learn More
The Urgent Need for Proactive Medication Safety
1.5M
ER Visits
Annual emergency visits in the U.S. due to Adverse Drug Events, with nearly 500,000 requiring hospitalization (CDC, 2023)
350K
Hospitalizations
Patients hospitalized yearly from medication complications (AHRQ Patient Safety Network, 2024)
128K
Deaths
Annual fatalities from medication errors and adverse events (JAMA analysis, 2023)
$177B
Economic Impact
Annual healthcare costs associated with adverse drug events (NIH & Health Economics Research, 2024)
Sources: Centers for Disease Control and Prevention (CDC), Agency for Healthcare Research and Quality (AHRQ), Journal of the American Medical Association (JAMA), and National Institutes of Health (NIH). All 2025 projections based on current trend analysis from the Institute for Safe Medication Practices.
RxReport: Real-Time Drug Safety Intelligence
Monitor Emerging Trends
Track medication events across populations in real-time, identifying patterns before they become widespread problems.
Predictive Analytics
Leverage AI-powered insights to anticipate potential safety concerns based on real-world outcomes and patient data.
Shareable Reports
Generate comprehensive safety documentation for clinical education, regulatory submissions, and public health initiatives.
Workflow Integration
Seamlessly incorporate safety data into existing pharmacy systems, EHRs, and clinical decision support tools.
Designed for Healthcare Innovators
Hospital Systems & PBMs
Enhance medication safety protocols and reduce adverse events through proactive monitoring and intervention.
Academic Researchers
Access anonymized real-world data to advance pharmacovigilance research and improve clinical outcomes.
Pharmacy Associations
Empower members with cutting-edge tools to improve patient safety and enhance professional practice.
AI/Clinical Tool Developers
Integrate robust medication safety data into decision support systems and digital health platforms.
Smart Data Technology Stack
Actionable Intelligence
Turning complex data into clinical insights
Machine Learning Models
Trained to detect safety signals and demographic impacts
Rich Data Sources
FDA MedWatch, anonymized ADEs, pharmacovigilance datasets
Natural Language Processing
Converting patient-reported events into structured data
Our platform applies advanced AI techniques to transform disparate medication safety data into a comprehensive intelligence system that grows smarter with each new data point.
Supporting National Public Health Goals
Timely Safety Trends
Provide healthcare stakeholders with early access to emerging medication safety signals.
Transparent Communication
Facilitate evidence-based discussions between providers and patients about medication risks.
3
Educational Campaigns
Support targeted initiatives that prevent adverse events through improved awareness.
Public Trust
Build confidence in medication safety through data-driven transparency and information sharing.
Collaboration Opportunities
Pilot Partnerships
Join our early adopter program to help shape the future of medication safety intelligence, with customized implementation support and priority feature development.
Strategic Licensing
Integrate RxReport.ai capabilities into your existing platforms through flexible licensing options tailored to your organization's specific needs and user base.
Research Collaboration
Partner with our data science team to advance pharmacovigilance research, develop novel safety algorithms, or create specialized applications for specific medication classes.
Educational Programs
Leverage our platform for continuing education initiatives, pharmacy school training, or public health campaigns focused on medication safety awareness.
Strategic Acquisition Opportunity
White-Label Integration
RxReport.ai can be fully customized with your organization's branding, user experience, and workflow requirements while maintaining all core functionality and data intelligence capabilities.
Exclusive Market Rights
Acquisition includes complete intellectual property rights to our proprietary algorithms, data processing systems, and user interfaces, providing a significant competitive advantage in the medication safety space.
Technical Transfer
Our technical team can provide comprehensive knowledge transfer, implementation support, and ongoing consultation to ensure seamless integration with your existing technology infrastructure.
Growth Potential
The platform offers multiple expansion pathways including integration with telehealth services, pharmaceutical research applications, and international market adaptation with region-specific regulatory features.